(Q33953508)

30 July 2017

1 reference

title

Growth factors, receptors, and molecular alterations in pancreatic cancer. Putting it all together (English)

1 reference

30 July 2017

Ulrich CD 2nd

1

1 reference

30 July 2017

1 May 2000

1 reference

Medical Clinics of North America

30 July 2017

1 reference

30 July 2017

84

1 reference

30 July 2017

697-705, xi-xii

1 reference

30 July 2017

3

1 reference

Gene therapy for pancreatic and biliary malignancies

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

Attenuated ALK5 receptor expression in human pancreatic cancer: correlation with resistance to growth inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

Imbalance of expression of matrix metalloproteinases (MMPs) and tissue inhibitors of the matrix metalloproteinases (TIMPs) in human pancreatic carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

Hereditary pancreatic adenocarcinoma. A clinical perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

Cancer surveillance of patients from familial pancreatic cancer kindreds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

Enhanced expression of urokinase plasminogen activator and its receptor in pancreatic carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

Invasion and metastasis in pancreatic cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

Optimization of treatment conditions for studying the anticancer effects of retinoids using pancreatic adenocarcinoma as a model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

Biliopancreatic malignancy current diagnostic possibilities: an overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

bax, but not bcl-2, influences the prognosis of human pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

Amphiregulin antisense oligonucleotide inhibits the growth of T3M4 human pancreatic cancer cells and sensitizes the cells to EGF receptor-targeted therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

Increased risk of cancer in the Peutz-Jeghers syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

Molecular and immunochemical analyses of RB1 and cyclin D1 in human ductal pancreatic carcinomas and cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

Altered expression of insulin-like growth factor II receptor in human pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

Characterization of keratinocyte growth factor and receptor expression in human pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

Concomitant over-expression of vascular endothelial growth factor and its receptors in pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

Retinoic acid receptor beta regulates growth and differentiation in human pancreatic carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

Molecular genetic alterations in ductal pancreatic adenocarcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

The TGF-beta signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

Bone morphogenetic protein 2 exerts diverse effects on cell growth in vitro and is expressed in human pancreatic cancer in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

Inhibition of basal and mitogen-stimulated pancreatic cancer cell growth by cyclin D1 antisense is associated with loss of tumorigenicity and potentiation of cytotoxicity to cisplatinum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

Presence of two signaling TGF-beta receptors in human pancreatic cancer correlates with advanced tumor stage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

Genetics and pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

Medical genetic study of eight pancreatic cancer-prone families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

Pancreatic carcinoma and hereditary nonpolyposis colorectal cancer: a family study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

Pancreatic cancer surveillance in a high-risk cohort. Is it worth the cost?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

Id-1 and Id-2 are overexpressed in pancreatic cancer and in dysplastic lesions in chronic pancreatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

TGFbeta signaling: receptors, transducers, and Mad proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

Isolation of DNA sequences amplified at chromosome 19q13.1-q13.2 including the AKT2 locus in human pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

Cholecystokinin-A receptor messenger RNA expression in human pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

Exocrine pancreatic tumours and their histological classification. A study based on 167 autopsy and 97 surgical cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

Frequent codeletion of p16/MTS1 and p15/MTS2 and genetic alterations in p16/MTS1 in pancreatic tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

The Risk of Cancer among Patients with Cystic Fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

The National Cancer Data Base report on pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

Culture of human main pancreatic duct epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

EUS and K-ras analysis of pure pancreatic juice collected via a duodenoscope after secretin stimulation for diagnosis of pancreatic mass lesion: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

Pancreatic cancer: can we screen? How should we stage?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

Genetic prodrug activation therapy for pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

Molecular pattern of ductal pancreatic cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

Secretin and vasoactive intestinal peptide receptors: members of a unique family of G protein-coupled receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

Angiogenesis and anti-angiogenesis: perspectives for the treatment of solid tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

Nutritional support during treatment of biliopancreatic malignancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

Expression of a truncated EGF receptor is associated with inhibition of pancreatic cancer cell growth and enhanced sensitivity to cisplatinum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

In vitro influences between pancreatic adenocarcinoma cells and pancreatic islets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

Hereditary pancreatitis and pancreatic carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

Hereditary pancreatitis: new insights, new directions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

Nerve growth factor expression correlates with perineural invasion and pain in human pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

Enhanced expression of transforming growth factor beta isoforms in pancreatic cancer correlates with decreased survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Role of fibroblast growth factors and their receptors in pancreatic cancer and chronic pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970252-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0025-7125(05)70252-2

1 reference

30 July 2017

1 reference

PubMed ID

10872426